MwanzoGUD • TSE
add
Knight Therapeutics Inc
Bei iliyotangulia
$ 5.83
Bei za siku
$ 5.76 - $ 5.91
Bei za mwaka
$ 5.09 - $ 6.45
Thamani ya kampuni katika soko
586.96M CAD
Wastani wa hisa zilizouzwa
elfu 78.08
Uwiano wa bei na mapato
138.14
Mgao wa faida
-
Ubadilishanaji wa msingi
TSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(CAD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 96.86M | 30.55% |
Matumizi ya uendeshaji wa biashara | 43.31M | 26.28% |
Mapato halisi | 10.74M | 144.13% |
Kiwango cha faida halisi | 11.08 | 133.79% |
Mapato kwa kila hisa | 0.11 | 175.39% |
EBITDA | 6.46M | -17.88% |
Asilimia ya kodi ya mapato | -36.32% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(CAD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 172.84M | 1.75% |
Jumla ya mali | 963.80M | 1.94% |
Jumla ya dhima | 168.69M | -15.07% |
Jumla ya hisa | 795.10M | — |
hisa zilizosalia | 100.05M | — |
Uwiano wa bei na thamani | 0.73 | — |
Faida inayotokana na mali | -0.77% | — |
Faida inayotokana mtaji | -0.88% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(CAD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 10.74M | 144.13% |
Pesa kutokana na shughuli | 1.47M | -91.81% |
Pesa kutokana na uwekezaji | 18.05M | 1,049.45% |
Pesa kutokana na ufadhili | -15.35M | 56.99% |
Mabadiliko halisi ya pesa taslimu | 6.35M | 134.04% |
Mtiririko huru wa pesa | 4.96M | -91.80% |
Kuhusu
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Ilianzishwa
2014
Makao Makuu
Tovuti
Wafanyakazi
745